A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: Development, utilization and withdrawal

Novartis Foundation Symposium

Volumn 238, Issue , 2001, Pages 153-179

  Kapikian, Albert Z ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ROTAVIRUS VACCINE;

CHILD; DEVELOPING COUNTRY; DIARRHEA; DRUG CONTRAINDICATION; HUMAN; IMMUNOLOGY; INFANT; LICENSING; MEDICAL ETHICS; REVIEW; RISK; STANDARD; UNITED STATES; VACCINATION; VIROLOGY; VIRUS INFECTION;

CHILD; DEVELOPING COUNTRIES; DIARRHEA; ETHICS, CLINICAL; HUMANS; INFANT; LICENSURE; RISK; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES; VACCINATION; VACCINES, ATTENUATED;

EID: 0035236196     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (30)

1. ACIP 1999 Transcript of Advisory Committee on Immunization Practices (ACIP) Meeting at CDC, October 22, 1999. N. Lee and Associates, Certified Court Reporters, Atlanta GA, vol 3, p 1-174
2. Bresee JS, Glass RI, Ivanoff B, Gentsch JR 1999 Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 17:2207-2222
3. CDC 1999a Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 48:1-23
4. CDC 1999b Intussusception among recipients of rotavirus vaccine - United States, 1998-1999. Morb Mortal Wkly Rep 48:577-581
5. CDC 1999c Withdrawal of rotavirus vaccine recommendation. Morb Mortal Wkly Rep 48:1007
6. Clark HF, Offit PA, Ellis RW et al 1996 WC3 reassortant vaccines in children. Arch Virol Suppl 12:187-198
7. Clements ML, Makhene MK, Mrukowicz et al 1999 Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7 - specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine 17:2715-2725
8. Glass RI, Gentsch J, Smith JC 1994 Rotavirus Vaccines: success by reassortment? Science 265:1389-1391
9. Hellems MA, Waggoner-Fountain L, Borowitz SM 2000 Association between intussusception and rotavirus gastroenteritis. Pediatric Res Program Issue 2000:1562 (abstr)
10. Hoshino Y, Kapikian AZ 2000 Rotavirus serotypes: classification and importance in epidemiology, immunity and vaccine development J Health Popul Nutr 18:5-14
11. Joensuu J, Koskenniemi E, Pang XL, Vesikari T 1997 Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350:1205-1209
12. Kapikian AZ, Chanock RM 1996 Rotaviruses. In: Fields BN, Knipe DM, Howley PM et al (eds) Fields Virology, 3rd edn. Lippincott-Raven, Philadelphia, PA, p1657-1708
13. Kapikian AZ, Hoshino Y, Chanock RM, Pérez-Schael I 1996 Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 174:565-572
14. Katsushima N 1981 Epidemiology, clinical features and diagnosis of intussusception (in Japanese). Jap J Pediatr Surg 13:563-570
15. Konno T, Suzuki H, Kutsuzawa T et al 1978 Human rotavirus infection in infants and young children with intussusception. J Med Virol 2:265-269
16. Matson 1996 Protective immunity against group A rotavirus infection and illness in infants. Arch Virol Suppl 12:129-139
17. Midthun K, Kapikian AZ 1996 Rotavirus vaccines: an overview. Clin Microbiol Rev J 9: 423-434
18. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM 1985 Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 53:949-954
19. Midthun K, Hoshino Y, Kapikian AZ, Chanock RM 1986 Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol 24:822-826
20. Mulcahy DL, Kamath KR, de Silva LM, Hodges S, Carter IW, Cloonan MJ 1982 A two-part study of the aetiological role in intussusception. J Med Virol 9:51-55
21. Nicolas JC, Ingrand D, Fortier B, Bricout F 1982 A one-year virological survey of acute intussusception in childhood. J Med Virol 9:267-271
22. Offit PA 1994 Immunologic determinants of protection against rotavirus disease. Curr Top Microbiol Immunol 185:229-254
23. Offit PA, Clark HF, Kapikian AZ 1997 Vaccines against rotavirus. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS (eds) New Generation Vaccines, 2nd edn. Marcel Dekker, New York, p 659-671
24. Pérez-Schael I, Guntiñas MJ, Pérez M et al 1997 Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 337: 1181-1187 (erratum: 1998 N Engl J Med 2:1002)
25. Rennels MB, Glass RI, Dennehy PH et al 1996 Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the National Multicenter trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 97:7-13
26. Rennels MB, Parashar UD, Holman RC, Le CT, Chang HG, Glass RI 1998 Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J 17:924-925
27. Santosham M, Moulton LH, Reid R et al 1997 Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 131:632-638
28. Staatz G, Alzen G, Heimann G 1998 Intestinal infection, the most frequent cause of invagination in childhood: results of a 10-year clinical study (in German). Klin Paediatr 210:61-64
29. Vesikari T 1996 Trials of oral bovine rhesus rotavirus vaccines in Finland: a historical account and present status. Arch Virol Suppl 12:177-186
30. World Health Organization 2000 Report of the meeting on future directions for rotavirus vaccine research in developing countries, Geneva 9-11 February 2000 p 1-62